Grant of Options

RNS Number : 0356W
Spectral MD Holdings, Ltd.
13 April 2023
 


Spectral MD Holdings, Ltd

("Spectral MD" or the "Company")

 

Grant of Options and Restricted Stock Units

 

LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary artificial intelligence (AI) algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options ("Options") over a total of 1,301,000 common stock of US$0.001 each in the Company ("Common Stock") to various employees, including a Director and Persons Discharging Managerial Responsibilities ("PDMR") as detailed below. The Options are granted under the 2018* and 2022** Long Term Incentive Plans ("LTIP"), vest over a three-year period from the date of grant, expire after 10 years and have an exercise price of 35 pence.

 

In addition, the Company announces that it has granted Restricted Stock Units ("RSUs") over 600,000 Common Stock to certain Non-Executive Directors. The RSUs are granted under the 2022 Long Term Incentive Plan, vest over a three-year period from the date of grant, are not subject to performance conditions and have no expiration date. Details are as follows:

 

Name

Options granted

Date of grant

Exercise price

Vesting period

Wensheng Fan, CEO

915,000

12 April 2023

35p

1/3 annually over 3 years

Nils Windler, CFO

200,000

12 April 2023

35p

1/3 annually over 3 years

 

 

Name

RSUs granted

Date of grant

Exercise price

Vesting period

Martin Mellish, Non-Executive Chairman

200,000

12 April 2023

Nil

50% on first anniversary of grant; 25% on second anniversary; 25% on third anniversary

Richard Cotton, Non-Executive Director

200,000

12 April 2023

Nil

50% on first anniversary of grant; 25% on second anniversary; 25% on third anniversary

Dr. Cynthia Cai, Non-Executive Director

200,000

12 April 2023

Nil

50% on first anniversary of grant; 25% on second anniversary; 25% on third anniversary

 

*Please refer to the Company's Admission Document for further information on the terms of the 2018 LTIP

 

**Please refer to the Company's announcement dated 1 September 2022 for further information on the terms of the 2022 LTIP

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

 

For further information please contact:

 

Spectral MD Holdings, Ltd.

investors.spectralmd.com

Wensheng Fan, Chief Executive Officer

via Walbrook PR

Nils Windler, Chief Financial Officer

 

 

 

SP Angel Corporate Finance LLP ( NOMAD and Joint Broker)

Tel: +44 (0)20 3470 0470

Stuart Gledhill/Harry Davies-Ball (Corporate Finance)

Vadim Alexandre/Rob Rees (Sales & Broking)

 

 

 

 

Stifel Nicolaus Europe Limited (Joint Broker)

Charles Hoare / Ben Maddison / Nick Harland /

Will Palmer-Brown

Tel: +44 (0)20 7710 7600

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com

Paul McManus / Louis Ashe-Jepson

Alice Woodings

 

Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393

 +44 (0)7407 804 654

 

 

About Spectral MD:  

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.

www.spectralmd.com

info@spectralmd.com

 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Wensheng Fan

2. 

Reason for the Notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectral MD Holdings, Ltd

b)

LEI

213800VXW1FVGWTCKL44

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Common Stock of  US$0.001 each   

Identification code

USU8457V1099

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.  35p

 

 915,000

 

d)

Aggregated information:

 Aggregated volume

 Price

 

Price(s)

Volume(s)

 35p

 

915,000

e)

Date of the transaction

12 April 2023

f)

Place of the transaction

Outside a trading venue   

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nils Windler

2. 

Reason for the Notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectral MD Holdings, Ltd

b)

LEI

213800VXW1FVGWTCKL44

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Common Stock of  US$0.001 each   

Identification code

USU8457V1099

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.  35p

 

 200,000

 

d)

Aggregated information:

 Aggregated volume

 Price

 

Price(s)

Volume(s)

 35p

 

200,000

e)

Date of the transaction

12 April 2023

f)

Place of the transaction

Outside a trading venue   

 

 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Martin Mellish

2. 

Reason for the Notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectral MD Holdings, Ltd

b)

LEI

213800VXW1FVGWTCKL44

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Common Stock of  US$0.001 each   

Identification code

USU8457V1099

b)

Nature of the transaction

Grant of Restricted Stock Units

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

 

 200,000

 

d)

Aggregated information:

 Aggregated volume

 Price

 

Price(s)

Volume(s)

 Nil

 

200,000

e)

Date of the transaction

12 April 2023

f)

Place of the transaction

Outside a trading venue   

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Cotton

2. 

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectral MD Holdings, Ltd

b)

LEI

213800VXW1FVGWTCKL44

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Common Stock of  US$0.001 each   

Identification code

USU8457V1099

b)

Nature of the transaction

Grant of Restricted Stock Units

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

 

 200,000

 

d)

Aggregated information:

 Aggregated volume

 Price

 

Price(s)

Volume(s)

 Nil

 

200,000

e)

Date of the transaction

12 April 2023

f)

Place of the transaction

Outside a trading venue   

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr. Cynthia Cai

2. 

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectral MD Holdings, Ltd

b)

LEI

213800VXW1FVGWTCKL44

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Common Stock of  US$0.001 each   

Identification code

USU8457V1099

b)

Nature of the transaction

Grant of Restricted Stock Units

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

 

 200,000

 

d)

Aggregated information:

 Aggregated volume

 Price

 

Price(s)

Volume(s)

 Nil

 

200,000

e)

Date of the transaction

12 April 2023

f)

Place of the transaction

Outside a trading venue   

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGMDNZVGFZM
UK 100

Latest directors dealings